ES2065342T3 - Nuevas formas galenicas de huevos de codorniz para administracion por via per- y sublingual en el tratamiento de las enfermedades alergicas y su procedimiento de preparacion. - Google Patents

Nuevas formas galenicas de huevos de codorniz para administracion por via per- y sublingual en el tratamiento de las enfermedades alergicas y su procedimiento de preparacion.

Info

Publication number
ES2065342T3
ES2065342T3 ES88420341T ES88420341T ES2065342T3 ES 2065342 T3 ES2065342 T3 ES 2065342T3 ES 88420341 T ES88420341 T ES 88420341T ES 88420341 T ES88420341 T ES 88420341T ES 2065342 T3 ES2065342 T3 ES 2065342T3
Authority
ES
Spain
Prior art keywords
per
codorniz
eggs
new
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88420341T
Other languages
English (en)
Inventor
Epouse Ayache Josiane Clairet
Jean-Jacques Ayache
Georges Bruttmann
Patrick Pedrali
Serge Robert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medibrevex
Original Assignee
Medibrevex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8714475A external-priority patent/FR2621484B1/fr
Application filed by Medibrevex filed Critical Medibrevex
Application granted granted Critical
Publication of ES2065342T3 publication Critical patent/ES2065342T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

ESTAS NUEVAS FORMAS GELANICAS ESTAN FORMADAS POR ESTRACTOS DE HUEVOS DEW CODORNIZ REALIZADOS EN DILUCION HAHENMANIENNA A PARTIR DE UNA SOLUCION MADRE, CON UNA MEZCLA DE YEMA Y DE CLARA DE HUEVOS, CONTENIDOS EN CANTIDADES ESTRICTAMENTE CONTROLADAS Y REPRODUCIBLES EN SOPORTES PREVISTOS PARA LA IVERNACION PROGRESIVA DEL PRINCIPIO ACTIVO POR VIA PER Y SUBLINGUAL. SU PROCEDIMIENTO DE PREPARACION CONSISTE EN REALIZAR LAS DILUCIONES HAHNEMANIENNAS A PARTIR DE UNA SOLUCION MADRE OBTENIDA POR TRITURACION CON UNA MEZCLA DE YEMAS Y CLARAS DE HUEVO.
ES88420341T 1987-10-08 1988-10-07 Nuevas formas galenicas de huevos de codorniz para administracion por via per- y sublingual en el tratamiento de las enfermedades alergicas y su procedimiento de preparacion. Expired - Lifetime ES2065342T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8714475A FR2621484B1 (fr) 1987-10-08 1987-10-08 Nouvelles formes galeniques d'oeufs de caille pour administration par voie per- et sublinguale dans le traitement des maladies allergiques et leur procede de preparation
FR878717252A FR2624013B2 (fr) 1987-10-08 1987-12-04 Application comme medicaments utiles pour le traitement allopathique des maladies allergiques de formes galeniques d'oeufs de caille

Publications (1)

Publication Number Publication Date
ES2065342T3 true ES2065342T3 (es) 1995-02-16

Family

ID=26226275

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88420341T Expired - Lifetime ES2065342T3 (es) 1987-10-08 1988-10-07 Nuevas formas galenicas de huevos de codorniz para administracion por via per- y sublingual en el tratamiento de las enfermedades alergicas y su procedimiento de preparacion.

Country Status (8)

Country Link
EP (1) EP0315552B1 (es)
JP (1) JPH01128932A (es)
AT (1) ATE115408T1 (es)
CA (1) CA1328600C (es)
DE (1) DE3852473T2 (es)
ES (1) ES2065342T3 (es)
FR (1) FR2624013B2 (es)
GR (1) GR3015072T3 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2680687A1 (fr) * 1991-08-29 1993-03-05 Etienne Marie Christine Compositions pharmaceutiques homeopathiques utilisees pour la fabrication de medicaments destines au traitement des maladies causees par des erreurs metaboliques et au traitement des maladies virales.
RU2161955C1 (ru) * 1999-07-16 2001-01-20 Эпштейн Олег Ильич Способ изменения физико-химических или физико-химических и биологических свойств вещества
FR2810550B1 (fr) * 2000-06-27 2004-10-08 Medibrevex Nouvelle formes galeiques solubles d'oeufs de caille a usage medicamenteux pour lavage oculaire et nasale et leurs procedes de fabrication
FR2811898B1 (fr) * 2000-07-18 2003-12-12 Medibrevex Formes galeniques medicamenteuses homeopathiques d'allergenes impregnes sur un support biologiquement actif pour desensibilisation specifique par voie sublinguale et leur procede de fabrication
FR2813531B1 (fr) * 2000-09-06 2003-02-14 Medibrevex Formes galeniques d'oligoelements incorpores dans un excipient biologiquement actif d'homogenat d'oeufs de caille et leur procede de fabrication
FR2836379B1 (fr) * 2002-02-28 2007-06-01 Dit Bon Michel Betend Formes galeniques solides de medicaments homeopathiques, dont les allergenes ou antigenes, en dilutions homeopathiques pour preparation extemporanee pour un seul individu pour administration sublinguale
EP2073822A4 (en) * 2006-10-12 2010-04-14 United Paragon Associates Inc METHOD FOR PRODUCING LIQUID COMPONENTS OF EGGS
BE1026978B1 (fr) 2019-01-23 2020-08-24 Pascal Melsens Procede de production d'ovomucoïdes et d'ovoinhibiteurs a partir d'un lot d'œufs de caille coturnix coturnix japonica

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2356426A1 (fr) * 1976-06-29 1978-01-27 Truffier Jean Claude Fraction ovomucoide du blanc de l'oeuf de caille, ayant des proprietes antiproteasiques
FR2472391A1 (fr) * 1979-12-28 1981-07-03 Truffier Jean Claude Lyophilisat d'oeuf de caille pour le traitement des maladies allergiques
FR2477017A1 (fr) * 1980-02-29 1981-09-04 Lyore Labo Composition en poudre a base d'oeufs de cailles et son application comme medicament
FR2538248B1 (fr) * 1982-12-28 1986-08-22 Interkemia Vegyipari Gazdasagi Compositions stabilisees a base d'oeufs de caille, en particulier a usages domestiques
HU194740B (en) * 1984-07-24 1988-03-28 Egal Vegyipari Koezoes Vallala Process for preparing roborating composition of quail egg base

Also Published As

Publication number Publication date
FR2624013B2 (fr) 1991-07-12
EP0315552B1 (fr) 1994-12-14
FR2624013A2 (fr) 1989-06-09
DE3852473T2 (de) 1995-05-11
EP0315552A1 (fr) 1989-05-10
ATE115408T1 (de) 1994-12-15
CA1328600C (fr) 1994-04-19
DE3852473D1 (de) 1995-01-26
GR3015072T3 (en) 1995-05-31
JPH01128932A (ja) 1989-05-22

Similar Documents

Publication Publication Date Title
ES2065342T3 (es) Nuevas formas galenicas de huevos de codorniz para administracion por via per- y sublingual en el tratamiento de las enfermedades alergicas y su procedimiento de preparacion.
Porter et al. Dieldrin and DDT: effects on sparrow hawk eggshells and reproduction
ES2058592T3 (es) El uso de sustancias activas fisiologicamente para la fabricacion de medicamentos para enfermedades cerebrales y neuronales.
Brion et al. Alzheimer's disease and tau proteins
KR950702427A (ko) 수정된 껍질알을 포함하는 조성물(Composition comprising fertilised shell eggs)
ES2177538T3 (es) Espiro piperidinas y homologos que promueven la liberacion de la hormona del crecimiento.
PT88985A (pt) Processo para a preparacao de composicoes farmaceuticas nasais e ou oftalmicas contendo azelastina
DE69309701D1 (de) Zusammensetzungen mit verzögerter wirkstoffabgabe zur behandlung periodontaler erkrankungen
ES2163442T3 (es) Utilizacion de particulas de una sal de calcio biocompatible y bio-reabsorbible como ingrediente activo en la preparacion de un medicamento destinado para el tratamiento local de enfermedades desmineralizantes de los huesos.
ES2194935T3 (es) Preparados estables de transglutaminasa y procedimiento para su preparacion.
ES2019570B3 (es) Dispositivo para el tratamiento termico del cuello de los preformados.
Anderson et al. The intestinal absorption of antigenic protein by normal infants.
ES2105225T3 (es) Control de los residuos de medicamentos veterinarios en la carne fresca.
NO883750D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
ATE78696T1 (de) Arzneimittelzubereitung zur behandlung des immunmangels.
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
BR7100718D0 (pt) Processo de fabricacao de partes condutoras de tecidos humanos ou animal para reconstituicao de partes especificas lesadas ou destruidas do corpo humano ou animal
Shah et al. Trichofolliculoma–'troll hair'dermoscopy.
Ferguson et al. Bone strength of caged layers as affected by portland cement and sodium bicarbonate
SU1692441A1 (ru) Противогнильцова паста
Lane et al. Infantile hemangioendothelioma of the parotid gland
Demian et al. Coexistent congenital cytomegalovirus and toxoplasmosis in a stillborn
Bercovitz et al. Phenothiazine: Experimental and clinical study of toxicity and anthelmintic value
SU556808A1 (ru) Препарат дл дезинфекции сосков вымени
Schalkoff et al. Effects of A23187 upon cortical granule exocytosis in eggs of Brachydanio

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 315552

Country of ref document: ES